by David Schwartz J.D. CPA, Executive Director | May 28, 2012 | All, Change Overview and Rationale, Formal Regulatory Remedies
Verena Ross, Executive Director of the European Securities and Markets Authority, says that the EU will lead by example in the harmonization and convergence of regulation of OTC derivatives. With the plan for the EU regulation of OTC derivatives, central...
by David Schwartz J.D. CPA, Executive Director | May 23, 2012 | All, Change Overview and Rationale, Formal Regulatory Remedies
In an April interview with BaFin Quarterly, Dr. Elke König, the head of Germany’s Federal Financial Supervisory Authority (BaFin), called for the swift regulation of shadow banking and derivatives. Critical of the FSB’s data gathering approach to shadow...
by David Schwartz J.D. CPA, Executive Director | May 20, 2012 | All, Formal Regulatory Remedies
Shadow banking, i.e., credit intermediation outside the regular banking system, may represent the greatest challenge facing financial policy makers today. Since the G20 Summits in Seoul in 2010 and Cannes in 2011, regulators have struggled to envision the changes...
by David Schwartz J.D. CPA, Executive Director | May 19, 2012 | All, Formal Regulatory Remedies, Procedural Changes
The rush to reregulate the financial markets after the financial crisis understandably has many concerned about unintended consequences. Regardless of good intentions, the fixes put in place by legislators, central bankers, and regulators no matter how well thought...
by David Schwartz J.D. CPA, Executive Director | May 17, 2012 | All, Formal Regulatory Remedies
The Federal Reserve Board, Federal Deposit Insurance Corporation, and the Office of the Comptroller of Currency have issued definitive guidance on supervisory expectations for stress testing by banking organizations with more than $10 billion in total consolidated...
